Abstract
Microarrays are a high throughput technology that allows the quantification of tens of thousands of RNA transcripts in a single reaction. This new technology offers the promise of comprehensive study of disease at a genomic level, potentially identifying novel molecular abnormalities, developing novel clinical biomarkers, and investigating drug efficacy. The ability to develop a molecular profile corresponding to a therapeutic effect is the basis for the concept of drug repositioning. With regard to prediction of clinical events, microarray technology has the potential to contribute to the development of sophisticated new biomarkers useful as predictors of disease etiology, outcome, and responsiveness to therapy—so-called personalized medicine. Currently progress in the field is hampered by a degree of skepticism about the reliability of microarray data and its relevance for clinical applications. Here we discuss possible pitfalls of transcriptomic analysis, review current developments in the cardiovascular area and address the use of transcriptomics for clinical applications.
Similar content being viewed by others
References
Archacki S, Wang Q (2004) Expression profiling of cardiovascular disease. Hum Genomics 1:355–370
Southern E, Mir K, Shchepinov M (1999) Molecular interactions on microarrays. Nat Genet 21:5–9
Barlaan EA, Sugimori M, Furukawa S, Takeuchi K (2005) Electronic microarray analysis of 16S rDNA amplicons for bacterial detection. J Biotechnol 115:11–21
Zimmermann K, Eiter T, Scheiflinger F (2003) Consecutive analysis of bacterial PCR samples on a single electronic microarray. J Microbiol Methods 55:471–474
Eiter T, Zimmermann K, Scheiflinger F (2002) Analysis of the detection limit on a microelectronic array. Biotechniques 33:494, 496
Edman CF, Raymond DE, Wu DJ, Tu E, Sosnowski RG, Butler WF et al (1997) Electric field directed nucleic acid hybridization on microchips. Nucleic Acids Res 25:4907–4914
’t Hoen PA, Turk R, Boer JM, Sterrenburg E, de Menezes RX, van Ommen GJ et al (2004) Intensity-based analysis of two-colour microarrays enables efficient and flexible hybridization designs. Nucleic Acids Res 32:e41
Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W et al (2006) Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol 24:1140–1150
Pozhitkov A, Noble PA, Domazet-Loso T, Nolte AW, Sonnenberg R, Staehler P et al (2006) Tests of rRNA hybridization to microarrays suggest that hybridization characteristics of oligonucleotide probes for species discrimination cannot be predicted. Nucleic Acids Res 34:e66
Alizadeh A, Eisen M, Davis RE, Ma C, Sabet H, Tran T et al (1999) The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 64:71–78
Barrans JD, Stamatiou D, Liew C (2001) Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem Biophys Res Commun 280:964–969
Sonenberg N, Pause A (2006) Signal transduction. Protein synthesis and oncogenesis meet again. Science 314:428–429
Iborra FJ, Jackson DA, Cook PR (2000) The path of RNA through nuclear pores: apparent entry from the sides into specialized pores. J Cell Sci 113(Pt 2):291–302
Tan PK, Downey TJ, Spitznagel EL Jr, Xu P, Fu D, Dimitrov DS et al (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 31:5676–5684
Brenner S (1999) Sillycon valley fever. Curr Biol 9:R671
Liang P (2000) Tutorial: gene discovery using differential display—Method analyzes differences in gene expression. Genet Eng News 20:37
Cooper S (2002) Cell cycle analysis and microarrays. Trends Genet 18:289–290
Couzin J (2006) Genomics. Microarray data reproduced, but some concerns remain. Science 313:1559
[Anon] (2006) Making the most of microarrays. Nat Biotechnol 24:1039
Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC et al (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151–1161
Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C et al (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365–371
Kittleson MM, Hare JM (2005) Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Trends Cardiovasc Med 15:130–138
Michelle M, Kittleson JMH (2005) Molecular signature analysis: the potential of gene-expression analysis in cardiomyopathy. Future Med 1:793–798
Hwang JJ, Allen PD, Tseng GC, Lam CW, Fananapazir L, Dzau VJ et al (2002) Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10:31–44
Grzeskowiak R, Witt H, Drungowski M, Thermann R, Hennig S, Perrot A et al (2003) Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 59:400–411
Yung CK, Halperin VL, Tomaselli GF, Winslow RL (2004) Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 83:281–297
Roy S, Khanna S, Kuhn DE, Rink C, Williams WT, Zweier JL et al (2006) Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol Genomics 25:364–374
Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E et al (2005) Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21:299–307
Shyamsundar R, Kim YH, Higgins JP, Montgomery K, Jorden M, Sethuraman A et al (2005) A DNA microarray survey of gene expression in normal human tissues. Genome Biol 6:R22
Lowes BD, Zolty R, Minobe WA, Robertson AD, Leach S, Hunter L et al (2006) Serial gene expression profiling in the intact human heart. J Heart Lung Transplant 25:579–588
Kaynak B, von HA, Mebus S, Seelow D, Hennig S, Vogel J et al (2003) Genome-wide array analysis of normal and malformed human hearts. Circulation 107:2467–2474
van’t Veer LJ, Dai H, van de Vijver V, He YD, Hart AA, Bernards R et al (2003) Expression profiling predicts outcome in breast cancer. Breast Cancer Res 5:57–58
Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC et al (2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8:68–74
Leung SY, Chen X, Chu KM, Yuen ST, Mathy J, Ji J et al (2002) Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A 99:16203–16208
Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD et al (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198:851–862
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937–1947
Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R et al (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350:1605–1616
Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani, Boer JM et al (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350:1617–1628
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K et al (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412:822–826
Calin GA, Ferracin M, Cimmino A, Di LG, Shimizu M, Wojcik SE et al (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793–1801
Lapointe J, Li C, Higgins JP, van de Rijn RM, Bair E, Montgomery K et al (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 101:811–816
Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442
Eshaque B, Dixon B (2006) Technology platforms for molecular diagnosis of cystic fibrosis. Biotechnol Adv 24:86–93
Salvado CS, Trounson AO, Cram DS (2004) Towards preimplantation diagnosis of cystic fibrosis using microarrays. Reprod Biomed Online 8:107–114
Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, Conte JV et al (2004) Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110:3444–3451
Mukherjee S, Tamayo P, Rogers S, Rifkin R, Engle A, Campbell C et al (2003) Estimating dataset size requirements for classifying DNA microarray data. J Comput Biol 10:119–142
Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C et al (2004) Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 24:1922–1927
Jensen KB, Watt FM (2006) Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci U S A 103:11958–11963
Barth AS, Hare JM (2006) The potential for the transcriptome to serve as a clinical biomarker for cardiovascular diseases. Circ Res 98:1459–1461
Nakhleh RE, Jones J, Goswitz JJ, Anderson EA, Titus J (1992) Correlation of endomyocardial biopsy findings with autopsy findings in human cardiac allografts. J Heart Lung Transplant 11:479–485
Morgun A, Shulzhenko N, Perez-Diez A, Diniz RV, Sanson GF, Almeida DR et al (2006) Molecular profiling improves diagnoses of rejection and infection in transplanted organs. Circ Res 98:e74–e83
Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA (2006) The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147:126–132
Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W et al (2003) Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 63:6069–6075
Deprimo SE, Wong LM, Khatry DB, Nicholas SL, Manning WC, Smolich BD et al (2003) Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification. BMC Cancer 3:3
Wessendorf S, Schwaenen C, Kohlhammer H, Kienle D, Wrobel G, Barth TFE et al (2003) Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 22:1425–1429
Evans RW, Williams GE, Baron HM, Deng MC, Eisen HJ, Hunt SA et al (2005) The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant 5:1553–1558
Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G et al (2006) Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6:150–160
Horwitz PA, Tsai EJ, Putt ME, Gilmore JM, Lepore JJ, Parmacek MS et al (2004) Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110:3815–3821
Deng MC, Eisen HJ, Mehra MR (2006) Methodological challenges of genomic research—the CARGO study. Am J Transplant 6:1086–1087
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heidecker, B., Hare, J.M. The use of transcriptomic biomarkers for personalized medicine. Heart Fail Rev 12, 1–11 (2007). https://doi.org/10.1007/s10741-007-9004-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-007-9004-7